Abstract: This paper analyzes the problems in the implementation of current GMP in China, and offers some suggestions on improving it for more efficient resources restructuring in pharmaceutical manufacturing enterprises. Focusing on marketing authorization holder mechanism and the commissioned production approach, the paper proposes specific strategies for upgrading the GMP system to improve the efficiency of resources restructuring in the large-, medium- and small-scale enterprises.